Strong correlation and high comparability of capillary electrophoresis and three different methods for HbA1c measurement in a population without hemoglobinopathy

References

• Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. WJD. 2015;6(6):850–867.
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas, 8th ed., 2017.
   Google Scholar
• Adapa D, Sarangi TK. A review on diabetic mellitus: complications, management and treatment modalities. Res Rev J Med Health Sci. 2015;4:1–17.
   Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
   PubMed Web of Science ®Google Scholar
• GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1260–1344.
   PubMed Web of Science ®Google Scholar
• International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–1334.
   PubMed Web of Science ®Google Scholar
• Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insight. 2016;11:95–104.
   PubMed Web of Science ®Google Scholar
• Welsh KJ, Kirkman MS, Sacks DB. Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Dia Care. 2016;39(8):1299–1306.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, England JD, Wiedmeyer H, et al. Defining the relationship between plasma glucose and HbA1c, analysis of glucose profiles and HbA1c in the diabetes control and complications trial. Diabetes Care. 2002;25(2):275–278.
   PubMed Web of Science ®Google Scholar
• White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244–1253.
   PubMed Web of Science ®Google Scholar
• Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, et al. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5:444–470.
   PubMedGoogle Scholar
• Sababayagam C, Liew G, Shankar A, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52:1279–1289.
   PubMed Web of Science ®Google Scholar
• Sandler CN, McDonnell ME. The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk. Cleve Clin J Med. 2016;83(suppl 1):S4–S10.
   PubMedGoogle Scholar
• Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40(1):78–89.
   PubMed Web of Science ®Google Scholar
• Weykamp C. HbA1c: A review of analytical and clinical aspects. Ann Lab Med. 2013;33(6):393–400.
   PubMed Web of Science ®Google Scholar
• Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol. 2009;3(3):439–445.
   PubMedGoogle Scholar
• Razi F, Rahnamaye Farzami M, Ebrahimi SA, et al. Comparative analytical performance of various HbA1c assays in Iran. Arch Iran Med. 2016;19(6):414–419.
   PubMed Web of Science ®Google Scholar
• NGSP. [home-page on the Internet] International Federation of Clinical Chemistry (IFCC). Standardization of HbA1c. Available from http://www.ngsp.org/docs/IFCCstd.pdf.
   Google Scholar
• Ou Z, Li Q, Liu W, et al. Elevated hemoglobin A2 as a marker for beta-thalassemia trait in pregnant women. Tohoku J Exp Med. 2011;223(3):223–226.
   PubMed Web of Science ®Google Scholar
• Abdel-Messih IY, Youssef SR, Mokhtar GM, et al. Clinical to molecular screening paradigm for beta-thalassemia carriers. Hemoglobin. 2015;39(4):240–246.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. User verification of precision and estimation of bias-third edition. EP15-A3. Wayne, PA, USA; 2014.
   Google Scholar
• Capillarys 3 Tera analyzer Leaflet. Sebia instruction manual. France, EVRY Cedex: Sebia;2016.
   Google Scholar
• Tina-quant® HbA1c Gen. 3 Leaflet for Cobas c311/c501 module/c502 module analyzers. Germany, Penzberg: Roche Diagnostics Ltd;2010.
   Google Scholar
• Hemoglobin A1c Kit (Enzymatic Assay Method) Leaflet for BS-360E Chemical Analyzer. China, Shenzhen: Mindray;2015.
   Google Scholar
• Automatic glycohemoglobin analyzer ADAMSTM A1c HA-8180V Leaflet. Japan, Kyoto: Arkray global bussiness inc;2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Method comparison and bias estimation using patient samples-third edition. EP09-A2. Wayne, PA, USA, 2014.
   Google Scholar
• Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25(2):141–151.
   PubMed Web of Science ®Google Scholar
• Bilic-Zulle L. Comparison of methods: Passing and Bablok regression. Biochem Med. 2011;21:49–52.
   PubMed Web of Science ®Google Scholar
• Sun Diagnostics. Recommended total allowable error limits. Available from http://www.mes-global.com/LiteratureRetrieve.aspx?ID=140407.
   Google Scholar
• Woodworth A, Korpi-Steiner N, Miller JJ, et al. Utilization of assay performance characteristics to estimate hemoglobin A1c result reliability. Clin Chem. 2014;60(8):1073–1079.
   PubMed Web of Science ®Google Scholar
• Weykamp CW, Mosca A, Gillery P, et al. The analytical goals for hemoglobin A (1c) measurement in IFCC units and National Glycohemoglobin Standardization Program Units are different. Clin Chem. 2011;57(8):1204–1206.
   PubMed Web of Science ®Google Scholar
• Aksungar FB, Serteser M, Coşkun A, et al. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement. Clin Chem Lab Med. 2013;51(8):e191–e193.
   PubMed Web of Science ®Google Scholar
• Klingenberg O, Furuset T, Hestbraten CR, et al. HbA1c analysis by capillary electrophoresis – comparison with chromatography and an immunological method. Scand J Clin Lab Invest. 2017;77(6):458–464.
   PubMed Web of Science ®Google Scholar
• Genc S, Gurdol F, Kanmaz-Ozer M, et al. The analytical performances of four differenct glycated hemoglobin methods. Med Chem. 2014;4(6):501–505.
   Google Scholar
• Herpol M, Lanckmans K, Neyghem SV, et al. Evaluation of the Sebia capillary 3 Tera and the Bio-Rad D-100 systems for the measurement of hemoglobin A1c. Am J Clin Pathol. 2016;146(1):67–77.
   PubMed Web of Science ®Google Scholar
• Warade J. Comparison of glycated hemoglobin with HPLC and capillary electrophoresis. Int J Res Med Sci. 2017;5(5):1976–1979.
   Google Scholar
• Kuna AT, Dukic K, Gabaj NN, et al. Comparison of enzymatic assay for HBA1c measurement (Abbott Architect) with capillary electrophoresis (Sebia Minicap Flex Piercing Analyzer). Lab Med. 2018;49:231–238
   PubMed Web of Science ®Google Scholar